» Articles » PMID: 38673859

Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38673859
Authors
Affiliations
Soon will be listed here.
Abstract

The dynamic relationship between heart failure and cancer poses a dual challenge. While cardiac remodeling can promote cancer growth and metastasis, tumor development can ameliorate cardiac dysfunction and suppress fibrosis. However, the precise mechanism through which cancer influences the heart and fibrosis is yet to be uncovered. To further explore the interaction between heart failure and cancer, we used the MDX mouse model, which suffers from cardiac fibrosis and cardiac dysfunction. A previous study from our lab demonstrated that tumor growth improves cardiac dysfunction and dampens fibrosis in the heart and diaphragm muscles of MDX mice. We used breast Polyoma middle T (PyMT) and Lewis lung carcinoma (LLC) cancer cell lines that developed into large tumors. To explore whether the aggressiveness of the cancer cell line is crucial for the beneficial phenotype, we employed a PyMT breast cancer cell line lacking integrin β1, representing a less aggressive cell line compared to the original PyMT cells. In addition, we examined immortalized and primary MEF cells. The injection of integrin β1 KO PyMT cancer cells and Mouse Embryo Fibroblasts cells (MEF) resulted in the improvement of cardiac function and decreased fibrosis in the heart, diaphragm, and skeletal muscles of MDX mice. Collectively, our data demonstrate that the cancer line aggressiveness as well as primary MEF cells are sufficient to impose the beneficial phenotype. These discoveries present potential novel clinical therapeutic approaches with beneficial outcome for patients with fibrotic diseases and cardiac dysfunction that do not require tumor growth.

References
1.
Awwad L, Aronheim A . Tumor Progression Reverses Cardiac Hypertrophy and Fibrosis in a Tetracycline-Regulated ATF3 Transgenic Mouse Model. Cells. 2023; 12(18). PMC: 10528851. DOI: 10.3390/cells12182289. View

2.
Juhas U, Ryba-Stanislawowska M, Szargiej P, Mysliwska J . Different pathways of macrophage activation and polarization. Postepy Hig Med Dosw (Online). 2015; 69:496-502. DOI: 10.5604/17322693.1150133. View

3.
Yang H, Chen Y, Gao C . Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization. Oncotarget. 2017; 8(59):99495-99503. PMC: 5725109. DOI: 10.18632/oncotarget.20111. View

4.
Hou S, Isaji T, Hang Q, Im S, Fukuda T, Gu J . Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Sci Rep. 2016; 6:18430. PMC: 4700444. DOI: 10.1038/srep18430. View

5.
Ley K . M1 Means Kill; M2 Means Heal. J Immunol. 2017; 199(7):2191-2193. DOI: 10.4049/jimmunol.1701135. View